home / lobbying / lobbying_filings_raw

lobbying_filings_raw: dafdb29f-3fd6-4e07-9e11-6c4aa2d3030f

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
dafdb29f-3fd6-4e07-9e11-6c4aa2d3030f Q2 41454 WILLIAMS AND JENSEN, PLLC 151552 BIOGEN IDEC 2016 second_quarter 2016-07-13T15:03:25.810000-04:00 50000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/dafdb29f-3fd6-4e07-9e11-6c4aa2d3030f/", "filing_uuid": "dafdb29f-3fd6-4e07-9e11-6c4aa2d3030f", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2016, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/dafdb29f-3fd6-4e07-9e11-6c4aa2d3030f/print/", "filing_document_content_type": "text/html", "income": "50000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "TJ Hartten", "dt_posted": "2016-07-13T15:03:25.810000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "701 8th Street, NW", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 41454, "url": "https://lda.senate.gov/api/v1/registrants/41454/", "house_registrant_id": 30771, "name": "WILLIAMS AND JENSEN, PLLC", "description": "Lobbying Law Firm", "address_1": "1201 Pennsylvania Avenue, NW", "address_2": "Suite 800", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ISABELLA QUINN", "contact_telephone": "+1 202-659-8201", "dt_updated": "2026-01-30T10:10:58.206597-05:00"}, "client": {"id": 151552, "url": "https://lda.senate.gov/api/v1/clients/151552/", "client_id": 1006601, "name": "BIOGEN IDEC", "general_description": "Biotechnology company that develops biopharmaceutical therapies", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2014-12-01"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "CMMI Medicare Part B demonstration; General education about policies impacting pharmaceutical development, approval, and reimbursement, including Medicare payment policies.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 61426, "prefix": null, "prefix_display": null, "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 18077, "prefix": null, "prefix_display": null, "first_name": "GEORGE", "nickname": null, "middle_name": null, "last_name": "OLSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65303, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": "BOOK", "last_name": "MULLEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Issues related to newborn screening programs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 61426, "prefix": null, "prefix_display": null, "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": "Shared employee, Ofc of the Speaker & Ofc of VA 7; Sr. Policy Adv, Maj Leader, Rep Cantor; Sr Policy Adv, Rep Whip, Rep Cantor; Sr Policy Adv, Majority Whip Rep. Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox", "new": true}, {"lobbyist": {"id": 14682, "prefix": null, "prefix_display": null, "first_name": "SUSAN", "nickname": null, "middle_name": null, "last_name": "HIRSCHMANN", "suffix": null, "suffix_display": null}, "covered_position": "COS, Rep Van Hilleary and Majority Whip", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "General education about policies impacting pharmaceutical development, approval, and reimbursement; 340 B program; 21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 61426, "prefix": null, "prefix_display": null, "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 18077, "prefix": null, "prefix_display": null, "first_name": "GEORGE", "nickname": null, "middle_name": null, "last_name": "OLSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65303, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": "BOOK", "last_name": "MULLEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); medical research at NIH.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 61426, "prefix": null, "prefix_display": null, "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 37173, "prefix": null, "prefix_display": null, "first_name": "KARINA", "nickname": null, "middle_name": null, "last_name": "LYNCH", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 18077, "prefix": null, "prefix_display": null, "first_name": "GEORGE", "nickname": null, "middle_name": null, "last_name": "OLSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65303, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": "BOOK", "last_name": "MULLEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 30771 DC DC US US Biotechnology company that develops biopharmaceutical therapies 0 0        

Links from other tables

  • 4 rows from filing_uuid in lobbying_activities
  • 5 rows from filing_uuid in lobbying_lobbyists
  • 0 rows from filing_uuid in lobbying_affiliated_orgs
Powered by Datasette · Queries took 1.122ms